| Danielle Lemieux, APRN-BC | |
|
5 Washington Pl Ste 1a, Bedford, NH 03110-6771 | |
| (603) 663-8060 | |
| Not Available |
| Full Name | Danielle Lemieux |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 5 Washington Pl Ste 1a, Bedford, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932833670 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 067741-21 (New Hampshire) | Secondary |
| 363L00000X | Nurse Practitioner | 067741-23 (New Hampshire) | Primary |
| Entity Name | Catholic Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972559904 PECOS PAC ID: 6103897129 Enrollment ID: O20060801000346 |
News Archive
Optegra Eye Health Care's flagship Central London hospital, situated in the prestigious Harley Street district, has given the gift of improved vision back to hundreds of people since first opening its doors in January 2016.
A new study showed that the proportion of young people admitting to having had unprotected sex with a new partner has risen over the past two years.
"N60" might not be the first thing that comes to mind when people think of Alzheimer's disease, but thanks to researchers from the United States, South Korea and France, this might change. That's because these researchers have found that the N60 section of a protein called "RanBP9" might be the key that unlocks an entirely new class of Alzheimer's drugs, and with them, hope. In a research report published online in The FASEB Journal, these scientists describe how the N60 fragment of the RanBP9 protein increases the production of the amyloid beta protein, which is present in excessive amounts in the brains of people with Alzheimer's disease.
New research has revealed that red blood cells function as critical immune sensors by binding cell-free DNA, called nucleic acid, present in the body's circulation during sepsis and COVID-19, and that this DNA-binding capability triggers their removal from circulation, driving inflammation and anemia during severe illness and playing a much larger role in the immune system than previously thought.
A popular drug commonly used to treat Alzheimer's disease has shown promise in laboratory and clinical trials for treating patients with sickle cell disease (SCD).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Lemieux, APRN-BC 1 Laurel St, Merrimack, NH 03054-3945 Ph: (603) 459-5413 | Danielle Lemieux, APRN-BC 5 Washington Pl Ste 1a, Bedford, NH 03110-6771 Ph: (603) 663-8060 |
News Archive
Optegra Eye Health Care's flagship Central London hospital, situated in the prestigious Harley Street district, has given the gift of improved vision back to hundreds of people since first opening its doors in January 2016.
A new study showed that the proportion of young people admitting to having had unprotected sex with a new partner has risen over the past two years.
"N60" might not be the first thing that comes to mind when people think of Alzheimer's disease, but thanks to researchers from the United States, South Korea and France, this might change. That's because these researchers have found that the N60 section of a protein called "RanBP9" might be the key that unlocks an entirely new class of Alzheimer's drugs, and with them, hope. In a research report published online in The FASEB Journal, these scientists describe how the N60 fragment of the RanBP9 protein increases the production of the amyloid beta protein, which is present in excessive amounts in the brains of people with Alzheimer's disease.
New research has revealed that red blood cells function as critical immune sensors by binding cell-free DNA, called nucleic acid, present in the body's circulation during sepsis and COVID-19, and that this DNA-binding capability triggers their removal from circulation, driving inflammation and anemia during severe illness and playing a much larger role in the immune system than previously thought.
A popular drug commonly used to treat Alzheimer's disease has shown promise in laboratory and clinical trials for treating patients with sickle cell disease (SCD).
› Verified 4 days ago
Ashley Danielle Blazon, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 160 S River Rd, Bedford, NH 03110 Phone: 603-537-1300 Fax: 603-310-0191 | |
Megan E Leonard, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 201 Riverway Pl, Bedford, NH 03110 Phone: 603-668-8400 | |
Mrs. Patricia A Pappal, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 360 Route 101, Unit 10, Bedford, NH 03110 Phone: 603-472-2846 | |
Ms. Amanda Sadat, MA Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 15 Constitution Dr, Suite 1a, Bedford, NH 03110 Phone: 603-310-5026 Fax: 603-218-6187 | |
Sarah Wheeler, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 160 S River Rd, Bedford, NH 03110 Phone: 603-537-1300 Fax: 603-310-0191 | |
Alex Mutuku, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 188 Nh 101, Bedford, NH 03110 Phone: 603-314-4700 | |
Ashley Marie Lougee, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25 Leavey Dr, Bedford, NH 03110 Phone: 603-472-7233 |